Skip to main content
. 2014 Jan 3;9(1):e84484. doi: 10.1371/journal.pone.0084484

Table 6. Summary of finding table for HCC patients with tumor size ≤3cm in NRCTs.

Event,% Effect estimate# Illustrative comparative risks(95%CI)Ψ
Indicators Subgroup Years No. of Participants (studies) RFA HR OR,95% CI I2 (%) P value NNT or NNH Assumed risk HR(control)(per 1000) Corresponding risk RFA(per 1000) Quality of evidence (GRADE)
Overall survival All 1-y 2782(14) 95.1 97.2 0.72[0.50,1.04] 17 0.08 47.6 967 955 (936 to 968) very low
3-y 3156(15) 80.5 86.4 0.71[0.48,1.05]& 68 0.09 16.9 811 753 (673 to 818) very low
5-y 2636(12) 71.1 93.3 0.62[0.43,0.90]& 67 0.01* 4.5 764 667 (582 to 744) very low
Child A 1-y 1632(9) 96.0 95.8 0.94[0.58,1.53] 22 0.81 500.0 981 980 (968 to 972) ⊕⊕ low
3-y 1632(9) 81.5 86.5 0.66[0.33,1.32]& 77 0.24 20.0 881 830 (710 to 907) very low
5-y 1386(6) 72.4 80.9 0.64[0.38,1.08]& 65 0.09 11.8 824 750 (640 to 835) very low
Single HCC 1-y 1516(8) 94.7 95.7 0.67[0.42,1.09] 9 0.11 100.0 982 973 (958 to 983) ⊕⊕ low
3-y 1516(8) 80.4 87.2 0.59[0.32,1.09]& 70 0.09 14.7 898 839 (738 to 906) very low
5-y 1516(8) 64.3 77.9 0.52[0.31,0.87]& 74 0.01* 7.4 773 639 (514 to 748) very low
Single + Child A 1-y 1009(6) 94.6 95.2 0.83[0.48,1.46] 43 0.52 166.7 990 988 (979 to 993) ⊕⊕ low
3-y 1009(6) 79.5 88.5 0.38[0.12,1.16]& 80 0.09 11.1 935 845 (633 to 943) ⊕⊕ low
5-y 978(5) 71.3 81.7 0.58[0.28,1.19]& 69 0.14 9.6 840 753 (595 to 862) very low
Disease-free survival All 1-y 1722(9) 71.6 85.2 0.43[0.34,0.55] 45 <0.00001* 7.4 854 716 (665 to 763) ⊕⊕ low
3-y 1722(9) 43.1 64.3 0.45[0.31,0.64]& 54 <0.0001* 4.7 604 407 (321 to 494) very low
5-y 1592(7) 24.8 46.2 0.50[0.26,0.97]& 83 0.04* 4.7 357 217 (126 to 350) ⊕⊕ low
Child A 1-y 772(4) 76.9 86.6 0.52[0.36,0.75] 45 0.0006* 10.3 876 771 (700 to 829) ⊕⊕ low
3-y 772(4) 57.7 71.7 0.55[0.40,0.74] 0 0.0001* 7.1 649 504 (425 to 578) ⊕⊕ low
5-y 627(2) 42.8 53.7 0.66[0.48,0.91] 0 0.01* 9.2 482 380 (309 to 459) ⊕⊕ low
Single HCC 1-y 1024(5) 78.7 86.4 0.54[0.39,0.75] 38 0.0003* 13.0 859 767 (704 to 820) ⊕⊕ low
3-y 1024(5) 53.5 68.7 0.55[0.43,0.72] 0 <0.0001* 6.6 615 468 (407 to 535) ⊕⊕ low
5-y 1024(5) 32.3 46.7 0.69[0.35,1.36]& 78 0.28 6.9 404 319 (192 to 480) very low
Single + Child A 1-y 717(3) 75.9 87.0 0.48[0.33,0.71] 38 0.0003* 9.0 898 809 (744 to 862) ⊕⊕⊕ moderate
3-y 717(3) 79.5 88.5 0.55[0.40,0.75] 80 0.09 11.1 712 576 (497 to 650) ⊕⊕ low
5-y 627(2) 42.8 53.7 0.66[0.48,0.91] 0 0.01* 9.2 482 380 (309 to 459) ⊕⊕ low
Recurrence-free survival All 1-y 1467(5) 78.8 77.6 1.02[0.79,1.31] 0 0.89 83.3 757 761 (711 to 803) ⊕⊕ low
3-y 1467(5) 44.5 50.6 0.85[0.69,1.05] 17 0.13 16.4 493 453 (402 to 505) ⊕⊕ low
5-y 1307(4) 29.2 37.4 0.76[0.40,1.43]& 83 0.39 12.2 368 307 (189 to 454) very low
Child A 1-y 1236(4) 77.8 76.7 1.05[0.80,1.38] 0 0.71 90.9 748 757 (725 to 820) ⊕⊕ low
3-y 1236(4) 46.2 50.9 0.88[0.70,1.11] 27 0.27 21.3 514 482 (425 to 540) ⊕⊕ low
5-y 1076(3) 32.9 38.7 0.81[0.36,1.83]& 89 0.61 17.2 370 322 (175 to 518) very low
Single HCC 1-y 899(3) 78.2 76.0 1.03[0.74,1.42] 0 0.87 45.5 757 762 (697 to 816) ⊕⊕ low
3-y 899(3) 49.0 52.2 0.96[0.73,1.26] 26 0.79 31.3 521 511 (443 to 578) ⊕⊕ low
5-y 899(3) 34.8 37.7 1.05[0.79,1.39] 37 0.75 34.5 370 381 (317 to 449) ⊕⊕ low
Single + Child A 1-y 668(2) 76.0 74.3 1.09[0.76,1.56] 0 0.63 58.8 748 764 (693 to 822) ⊕⊕ low
3-y 668(2) 55.1 53.0 1.07[0.78,1.46] 0 0.68 47.6 544 561 (482 to 635) very low
5-y 668(2) 44.5 39.7 1.17[0.86,1.61] 0 0.32 20.8 442 481 (405 to 560) very low
Recurrence All 1-y 490(2) 12.9 15.4 0.83[0.49,1.40] 0 0.48 40.0 163 139 (87 to 214) very low
3-y 490(2) 50.7 45.2 0.95[0.29,3.11]& 87 0.94 18.1 493 480 (220 to 751) very low
5-y 490(2) 66.2 59.0 0.95[0.21,4.28]& 91 0.94 13.9 638 626 (270 to 883) very low
Child A 1-y 116(1) 18.2 18.0 1.01[0.39,2.63] 0.98 500.0 180 181 (79to 366) ⊕⊕ low
3-y 116(1) 40.9 58.0 0.50[0.24,1.06] 0.07 5.8 580 408 (249 to 594) ⊕⊕⊕ moderate
5-y 116(1) 54.5 74.0 0.42[0.19,0.93] 0.03* 5.1 740 544 (351 to 726) ⊕⊕⊕ moderate
Complication rate All 1248(7) 7.1 16.0 0.44[0.29,0.65] 35 <0.0001* 11.2 66 30 (20 to 44) ⊕⊕ low
Child A 305(2) 11.2 31.1 0.36[0.12,1.12]& 55 0.08 5.0 290 128 (47 to 314) very low

Ψ: The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95%CI);

# Statistical method (M-H, random-effect model); & Statistical method (M-H, fixed-effect model).

,NNH(Number needed to harm);

‡,NNT(Number needed to treat);

*:p<0.05